Please wait a minute...
浙江大学学报(医学版)  2021, Vol. 50 Issue (3): 320-328    DOI: 10.3724/zdxbyxb-2021-0185
专题报道     
妊娠糖尿病患者孕前身体质量指数、孕期增重及血脂水平对妊娠结局的影响
徐恒(),马燕,张丽霞,梁朝霞,陈丹青*()
浙江大学医学院附属妇产科医院产科,浙江 杭州 310006
Impact of pre-pregnancy body mass index, weight gain and blood lipid level during pregnancy on pregnancy outcome in patients with gestational diabetes mellitus
XU Heng(),MA Yan,ZHANG Lixia,LIANG Zhaoxia,CHEN Danqing*()
Department of Obstetrics, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China
 全文: PDF(2231 KB)   HTML( 4 )
摘要:

目的:探讨妊娠糖尿病(GDM)孕妇及非GDM孕妇孕前身体质量指数(BMI)、孕期增重及孕期血脂水平对妊娠结局的影响。方法:选取2018年1月至2019年4月在浙江大学医学院附属妇产科医院产检并分娩的单胎、孕前无糖尿病、高血压疾病的12?650名孕妇,按照孕妇是否有GDM分为GDM组(2381例)和非GDM组(10?269例),再根据孕前BMI、孕期增重分亚组。各组间比较临床资料及妊娠结局,分析影响妊娠结局的相关因素。结果:在GDM和非GDM孕妇中,孕前超重和孕期增重过多均是大于胎龄儿、小于胎龄儿、初次剖宫产的独立相关因素(P<0.01或P<0.05),孕期增重过多亦是子痫前期的独立影响因素(P<0.05)。孕中期甘油三酯水平与大于胎龄儿、子痫前期、初次剖宫产、早产等不良妊娠结局独立相关(均P<0.01)。结论:控制孕期增重可以减少大于胎龄儿发生率,但孕期增重过少可能导致小于胎龄儿的发生;孕前控制BMI在正常范围可以有效减少大于胎龄儿、子痫前期及初次剖宫产的发生率;非GDM孕妇孕中期血脂水平异常可能与多个不良妊娠结局相关,需要积极的饮食指导或干预。

关键词: 妊娠糖尿病身体质量指数孕期增重血脂血糖妊娠结局    
Abstract:

Objective:To explore the effects of pre-pregnancy body mass index (BMI), weight gain and blood lipid level during pregnancy on pregnancy outcome in patients with and without gestational diabetes mellitus(GDM). Methods:A total of 12 650 singleton pregnant women without history of hypertension and diabetes who were admitted at Women’s Hospital, Zhejiang University School of Medicine for delivery from January 2018 to April 2019 were enrolled in the study. There were 2381 cases complicated with gestational diabetes (GDM group) and 10 269 cases without GDM (non-GDM group). The pre-pregnancy BMI and weight gain during pregnancy were documented in two groups. The factors related to perinatal outcome were analyzed. Results: In both GDM and non-GDM pregnant women, pre-pregnancy overweight and excessive weight gain during pregnancy were independent factors of large for gestational age infant (LGA), small for gestational age infant (SGA) and first cesarean section (P<0.01 orP<0.05). Excessive weight gain during pregnancy was also an independent risk factor of preeclampsia (P<0.05). Triglyceride levels in the second trimester were independently associated with multiple adverse pregnancy outcomes, such as LGA, preeclampsia, initial cesarean delivery, premature delivery.Conclusions: Controlling excessive or insufficient weight gain during pregnancy can significantly reduce the incidence of LGA and SGA. And controlling BMI before pregnancy can effectively reduce the incidence of LGA, preeclampsia and the first cesarean section. For non-GDM pregnant women, abnormal blood lipid levels in the second trimester may be closely related to multiple adverse pregnancy outcomes, and active dietary guidance or treatment is also required.

Key words: Gestational diabetes mellitus    Body mass index    Gestational weight gain    Blood lipid    Blood glucose    Pregnancy outcome
收稿日期: 2021-04-12 出版日期: 2021-08-16
CLC:  R714  
基金资助: 国家自然科学基金(81873839); 浙江省重点研发计划(2018C03010)
通讯作者: 陈丹青     E-mail: xuheng_911@zju.edu.cn;chendq@zju.edu.cn
作者简介: 徐 恒,住院医师,主要从事产科学研究;E-mail:xuheng_911@zju.edu.cn;https://orcid.org/0000-0002-8926-391X
服务  
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章  
徐恒
马燕
张丽霞
梁朝霞
陈丹青

引用本文:

徐恒,马燕,张丽霞,梁朝霞,陈丹青. 妊娠糖尿病患者孕前身体质量指数、孕期增重及血脂水平对妊娠结局的影响[J]. 浙江大学学报(医学版), 2021, 50(3): 320-328.

XU Heng,MA Yan,ZHANG Lixia,LIANG Zhaoxia,CHEN Danqing. Impact of pre-pregnancy body mass index, weight gain and blood lipid level during pregnancy on pregnancy outcome in patients with gestational diabetes mellitus. J Zhejiang Univ (Med Sci), 2021, 50(3): 320-328.

链接本文:

http://www.zjujournals.com/med/CN/10.3724/zdxbyxb-2021-0185        http://www.zjujournals.com/med/CN/Y2021/V50/I3/320

组别

n

年龄(岁)

初孕妇

经产妇

糖尿病家族史

孕前BMI(kg/m2

孕期增重(kg)

子痫前期

GDM组

2381

31±4

1114(46.8)

687(28.9)

67(2.8)

21.2±3.0

14±4

55(2.3)

非GDM组

10?269

29±3

5442(53.0)

2394(23.3)

99(1.0)

20.5±2.7

15±4

130(1.3)

t/χ2

261.01

29.83

32.21

51.07

137.84

68.76

14.62

P

<0.01

<0.01

<0.01

<0.01

<0.01

<0.01

<0.01

组别

n

孕中期血脂水平(mmol/L)

大于胎龄儿

小于胎龄儿

初次剖宫产

TC

TG

HDL

LDL

GDM组

2381

6.2±1.1

2.4±1.0

2.3±0.6

3.4±0.8

296(12.4)

118(5.0)

704(41.6)

非GDM组

10?269

6.2±1.0

2.2±0.9

2.4±0.5

3.4±0.9

808(7.9)

566(5.5)

2799(35.5)

t/χ2

2.27

88.86

12.42

2.56

50.53

1.17

21.74

P

>0.05

<0.01

<0.01

>0.05

<0.01

>0.05

<0.01

组别

n

孕晚期血脂水平(mmol/L)

胎儿窘迫

早产

产后出血

TC

TG

HDL

LDL

GDM组

2381

6.6±1.3

3.8±1.9

2.06±0.56

3.6±1.0

170(7.1)

140(5.9)

23(1.0)

非GDM组

10?269

6.7±1.3

3.4±1.6

2.12±0.56

3.7±1.0

723(7.0)

456(4.4)

101(1.0)

t/χ2

3.25

98.09

18.25

21.45

0.03

8.92

0.43

P

>0.05

<0.01

<0.01

<0.01

>0.05

<0.01

>0.05

表 1  GDM组与非GDM组一般情况及妊娠结局比较

组别

n

年龄(岁)

初孕妇

经产妇

糖尿病家族史

孕期增重(kg)

子痫前期

GDM组消瘦

390

29±4

216(55.4)

76(19.5)

3(0.8)

14±4

1(0.3)

体重正常

1740

31±4*

799(45.9)*

523(30.1)*

51(2.9)*

14±4*

34(2.0)*

超重

251

31±4*#

99(39.4)*#

88(35.1)*

13(5.2)*

13±5*#

20(8.0)*#

非GDM组消瘦

2236

29±3

1330(59.5)

403(18.0)

19(0.8)

15±4

15(0.7)

体重正常

7480

29±3*

3866(51.7)*

1836(24.5)*

72(1.0)

15±4*

97(1.3)*

超重

553

30±4*

246(44.5)*#

155(28.0)*

8(1.4)

13±4*#

18(3.3)*#

组别

n

大于胎龄儿

小于胎龄儿

初次剖宫产

胎儿窘迫

早产

产后出血

GDM组消瘦

390

16(4.1)

32(8.2)

93(29.6)

19(4.9)

17(4.4)

2(0.5)

体重正常

1740

224(12.9)*

76(4.4)*

505(41.5)*

123(7.1)

94(5.4)

16(0.9)

超重

251

56(22.3)*#

10(4.0)*#

106(65.0)*#

28(11.2)*#

29(11.6)*#

5(2.0)

非GDM组消瘦

2236

100(4.5)

174(7.8)

561(30.6)

138(6.2)

98(4.4)

17(0.8)

体重正常

7480

629(8.4)*

375(5.0)*

2032(36.0)*

537(7.2)

327(4.4)

75(1.0)

超重

553

79(14.3)*#

17(3.1)*#

206(51.8)*#

48(8.7)

31(5.6)

9(1.6)

表 2  GDM组与非GDM组不同孕前身体质量指数孕妇一般情况及妊娠结局比较

组别

n

年龄(岁)

初孕妇

经产妇

糖尿病家族史

孕前BMI(kg/m2

子痫前期

GDM组增重过少

586

31±4

272(46.4)

187(31.9)

15(2.6)

20.9±2.7

9(1.5)

增重适宜

1185

31±4*

549(46.3)

361(30.5)

30(2.5)

20.9±2.8

15(1.3)

增重过多

610

30±4*

293(48.0)

139(22.8)*#

22(3.6)

22.2±3.5*#

31(5.1)*#

非GDM组增重过少

1942

29±4

1023(52.7)

519(26.7)

16(0.8)

20.4±2.5

12(0.6)

增重适宜

5470

29±3

2906(53.1)

1280(23.4)*

46(0.8)

20.3±2.5*

49(0.9)

增重过多

2857

29±3*#

1513(53.0)

595(20.8)*#

37(1.3)

20.9±2.9*#

69(2.4)*#

组 别

n

大于胎龄儿

小于胎龄儿

初次剖宫产

胎儿窘迫

产后出血

GDM组增重过少

586

34(5.8)

46(7.8)

151(37.8)

42(7.2)

2(0.3)

?

增重适宜

1185

128(10.8)*

53(4.5)*

300(36.4)

78(6.6)

14(1.2)

?

增重过多

610

134(22.0)*#

19(3.1)*#

253(53.7)*#

50(8.2)

7(1.1)

?

非GDM组增重过少

1942

64(3.3)

170(8.8)

396(27.8)

125(6.4)

17(0.9)

?

增重适宜

5470

359(6.6)*

312(5.7)*

1435(34.2)*

362(6.6)

45(0.8)

?

增重过多

2857

385(13.5)*#

84(2.9)*#

968(42.8)*#

236(8.3)*#

39(1.4)

?

表 3  GDM组与非GDM组孕期不同增重孕妇一般情况及妊娠结局比较

影响因素

大于胎龄儿

小于胎龄儿

子痫前期

初次剖宫产

早产

胎儿窘迫

年龄至少35岁

2.911(2.025~4.186)**

1.942(1.305~2.889)**

经产妇

0.513(0.315~0.833)*

0.575(0.389~0.848)**

孕前BMI

?

消瘦

0.321(0.190~0.542)**

1.802(1.169~2.777)**

0.146(0.020~1.073)

0.654(0.498~0.860)**

0.890(0.521~1.520)

0.638(0.388~1.050)

超重

1.333(0.943~1.885)

1.214(0.604~2.441)

3.247(1.762~5.984)**

1.979(1.382~2.836)**

2.471(1.543~3.958)**

1.632(1.050~2.536)*

孕期增重

?

过少

0.496(0.333~0.738)**

1.856(1.231~2.798)**

1.204(0.518~2.798)

1.030(0.799~1.328)

1.656(1.107~2.478)*

过多

2.081(1.578~2.743)**

0.674(0.389~1.169)

2.916(1.521~5.590)**

1.737(1.363~2.212)**

0.855(0.539~1.356)

孕中期TG

1.283(1.147~1.437)**

1.309(1.088~1.576)**

1.183(1.060~1.322)**

1.284(1.120~1.472)**

孕中期LDL

1.368(1.037~1.804)*

表 4  影响妊娠糖尿病孕妇妊娠结局的相关因素分析结果

影响因素

大于胎龄儿

小于胎龄儿

子痫前期

初次剖宫产

早产

胎儿窘迫

年龄至少35岁

3.147(1.906~5.194)**

3.966(3.092~5.088)**

1.931(1.451~2.569)**

经产妇

1.416(1.203~1.666)**

0.521(0.409~0.664)**

0.329(0.188~0.574)**

1.275(1.027~1.582)*

0.724(0.596~0.881)**

糖尿病家族史

3.274(1.269~8.447)*

孕前BMI

?

消瘦

0.587(0.472~0.731)**

1.468(1.216~1.772)**

0.851(0.759~0.956)**

超重

1.267(0.975~1.645)

0.774(0.469~1.277)

1.564(1.266~1.932)**

孕期增重

?

过少

0.483(0.368~0.634)**

1.598(1.314~1.943)**

0.676(0.358~1.278)

0.733(0.641~0.839)**

1.864(1.499~2.317)**

0.985(0.798~1.216)

过多

2.160(1.849~2.524)**

0.524(0.409~0.672)**

2.667(1.837~3.872)**

1.351(1.213~1.505)**

0.764(0.595~0.981)*

1.269(1.070~1.506)**

孕中期TC

0.868(0.797~0.945)**

孕中期TG

1.299(1.147~1.470)**

1.192(1.125~1.263)**

1.189(1.087~1.299)**

孕中期HDL

0.680(0.582~0.795)**

0.427(0.289~0.632)**

孕中期LDL

1.172(1.076~1.277)**

1.123(1.012~1.247)*

表 5  影响非妊娠糖尿病孕妇妊娠结局的相关因素分析结果

影响因素

大于胎龄儿

小于胎龄儿

子痫前期

初次剖宫产

早产

胎儿窘迫

年龄至少35岁

2.911(2.025~4.186)**

1.942(1.305~2.889)**

经产妇

0.513(0.315~0.833)*

0.575(0.389~0.848)**

孕前BMI

?

消瘦

0.321(0.190~0.542)**

1.802(1.169~2.777)**

0.146(0.020~1.073)

0.654(0.498~0.860)**

0.890(0.521~1.520)

0.638(0.388~1.050)

超重

1.333(0.943~1.885)

1.214(0.604~2.441)

3.247(1.762~5.984)**

1.979(1.382~2.836)**

2.471(1.543~3.958)**

1.632(1.050~2.536)*

孕期增重

?

过少

0.496(0.333~0.738)**

1.856(1.231~2.798)**

1.204(0.518~2.798)

1.030(0.799~1.328)

1.656(1.107~2.478)*

过多

2.081(1.578~2.743)**

0.674(0.389~1.169)

2.916(1.521~5.590)**

1.737(1.363~2.212)**

0.855(0.539~1.356)

孕中期TG

1.283(1.147~1.437)**

1.309(1.088~1.576)**

1.183(1.060~1.322)**

1.284(1.120~1.472)**

孕中期LDL

1.368(1.037~1.804)*

表 4  影响妊娠糖尿病孕妇妊娠结局的相关因素分析结果

影响因素

大于胎龄儿

小于胎龄儿

子痫前期

初次剖宫产

早产

胎儿窘迫

年龄至少35岁

3.147(1.906~5.194)**

3.966(3.092~5.088)**

1.931(1.451~2.569)**

经产妇

1.416(1.203~1.666)**

0.521(0.409~0.664)**

0.329(0.188~0.574)**

1.275(1.027~1.582)*

0.724(0.596~0.881)**

糖尿病家族史

3.274(1.269~8.447)*

孕前BMI

?

消瘦

0.587(0.472~0.731)**

1.468(1.216~1.772)**

0.851(0.759~0.956)**

超重

1.267(0.975~1.645)

0.774(0.469~1.277)

1.564(1.266~1.932)**

孕期增重

?

过少

0.483(0.368~0.634)**

1.598(1.314~1.943)**

0.676(0.358~1.278)

0.733(0.641~0.839)**

1.864(1.499~2.317)**

0.985(0.798~1.216)

过多

2.160(1.849~2.524)**

0.524(0.409~0.672)**

2.667(1.837~3.872)**

1.351(1.213~1.505)**

0.764(0.595~0.981)*

1.269(1.070~1.506)**

孕中期TC

0.868(0.797~0.945)**

孕中期TG

1.299(1.147~1.470)**

1.192(1.125~1.263)**

1.189(1.087~1.299)**

孕中期HDL

0.680(0.582~0.795)**

0.427(0.289~0.632)**

孕中期LDL

1.172(1.076~1.277)**

1.123(1.012~1.247)*

表 5  影响非妊娠糖尿病孕妇妊娠结局的相关因素分析结果
1 COSSONE, BENBARAA, PHARISIENI, et al.Diagnostic and prognostic performances over 9 years of a selective screening strategy for gestational diabetes mellitus in a cohort of 18,775 subjects[J]Diabetes Care, 2013, 36( 3): 598-603.
doi: 10.2337/dc12-1428
2 HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: associations with neonatal anthropometrics[J]. Diabetes, 2009, 58(2): 453-459
3 BLACKM H, SACKSD A, XIANGA H, et al.The relative contribution of prepregnancy overweight and obesity, gestational weight gain, and IADPSG-defined gestational diabetes mellitus to fetal overgrowth[J]Diabetes Care, 2013, 36( 1): 56-62.
doi: 10.2337/dc12-0741
4 CATALANOP M, MCINTYREH D, CRUICKSHANKJ K, et al.The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes[J]Diabetes Care, 2012, 35( 4): 780-786.
doi: 10.2337/dc11-1790
5 DI BENEDETTOA, D’ANNAR, CANNATAM L, et al.Effects of prepregnancy body mass index and weight gain during pregnancy on perinatal outcome in glucose-tolerant women[J]Diabetes Metab, 2012, 38( 1): 63-67.
doi: 10.1016/j.diabet.2011.07.005
6 ALBERICOS, MONTICOM, BARRESIV, et al.The role of gestational diabetes, pre-pregnancy body mass index and gestational weight gain on the risk of newborn macrosomia: results from a prospective multicentre study[J]BMC Pregnancy Childbirth, 2014, 14( 1): 23.
doi: 10.1186/1471-2393-14-23
7 KIMS Y, SHARMAA J, SAPPENFIELDW, et al.Association of maternal body mass index, excessive weight gain, and gestational diabetes mellitus with large-for-gestational-age births[J]Obstet GynEcol, 2014, 123( 4): 737-744.
doi: 10.1097/AOG.0000000000000177
8 GILEADR, YANIV SALEMS, SERGIENKOR, et al.Maternal “isolated” obesity and obstetric complications[J]J Matern-Fetal Neonatal Med, 2012, 25( 12): 2579-2582.
doi: 10.3109/14767058.2012.716464
9 VOERMANE, SANTOSS, et al.Association of gestational weight gain with adverse maternal and infant outcomes[J]JAMA, 2019, 321( 17): 1702-1715.
doi: 10.1001/jama.2019.3820
10 Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization guideline[J]. Diabetes Res Clin Pract, 2014, 103(3): 341-363
11 YANGW, HANF, GAOX, et al.Relationship between gestational weight gain and pregnancy complications or delivery outcome[J]Sci Rep, 2017, 7( 1): 12531.
doi: 10.1038/s41598-017-12921-3
12 GOUB H, GUANH M, BIY X, et al.Gestational diabetes[J]Chin Med J, 2019, 132( 2): 154-160.
doi: 10.1097/CM9.0000000000000036
13 BOWERSK, LAUGHONS K, KIELYM, et al.Gestational diabetes, pre-pregnancy obesity and pregnancy weight gain in relation to excess fetal growth: variations by race/ethnicity[J]Diabetologia, 2013, 56( 6): 1263-1271.
doi: 10.1007/s00125-013-2881-5
14 ELLERBEC N, GEBREGZIABHERM, KORTEJ E, et al.Quantifying the impact of gestational diabetes mellitus, maternal weight and race on birthweight via quantile regression[J/OL]PLoS One, 2013, 8( 6): e65017.
doi: 10.1371/journal.pone.0065017
15 COSSONE, CUSSAC-PILLEGANDC, BENBARAA, et al.Pregnancy adverse outcomes related to pregravid body mass index and gestational weight gain, according to the presence or not of gestational diabetes mellitus: a retrospective observational study[J]Diabetes Metab, 2016, 42( 1): 38-46.
doi: 10.1016/j.diabet.2015.06.001
16 Institute of Medicine (US) and National Research Council (US) Committee to Reexamine IOM Pregnancy Weight Guidelines. Weight Gain During Pregnancy: Reexamining the Guidelines[M]. Washington (DC): National Academies Press, 2009: 2
17 朱丽, 张蓉, 张淑莲, 等. 中国不同胎龄新生儿出生体重曲线研制[J]. 中华儿科杂志, 2015, 53 (2): 97-103
ZHU Li, ZHANG Rong, ZHANG Shulian, et al. Chinese neonatal birth weight curve for different gestational age[J]. Chinese Journal of Pediatrics, 2015, 53(2): 97-103. (in Chinese)
18 QUINLIVANJ A, JULANIAS, LAML. Antenatal dietary interventions in obese pregnant women to restrict gestational weight gain to Institute of Medicine recommendations[J]Obstetrics GynEcol, 2011, 118( 6): 1395-1401.
doi: 10.1097/AOG.0b013e3182396bc6
19 DODDJ M, GRIVELLR M, CROWTHERC A, et al.Antenatal interventions for overweight or obese pregnant women: a systematic review of randomised trials[J]BJOG, 2010, 117( 11): 1316-1326.
doi: 10.1111/j.1471-0528.2010.02540.x
20 YEEL M, CHENGY W, INTURRISIM, et al.Gestational weight loss and perinatal outcomes in overweight and obese women subsequent to diagnosis of gestational diabetes mellitus[J/OL]Obesity, 2013, 21( 12): E770-E774.
doi: 10.1002/oby.20490
21 HARRISONC L, LOMBARDC B, STRAUSSB J, et al.Erratum: optimizing healthy gestational weight gain in women at high risk of gestational diabetes: a randomized controlled trial[J]Obesity, 2016, 24( 1): 268.
doi: 10.1002/oby.21392
[1] 陈云燕,吴琪,张丽霞,陈丹青,梁朝霞. 妊娠糖尿病孕妇孕中期口服葡萄糖耐量试验异常项数及孕期增重与不良妊娠结局的关系[J]. 浙江大学学报(医学版), 2021, 50(3): 313-319.
[2] 吴懿,蒋巍亮,杨晓军,黎文华,万荣,陆伦根,樊军卫,卢战军. 肝移植受者术后早期血清甘油三酯变化规律及其对术后糖尿病的预测价值[J]. 浙江大学学报(医学版), 2021, 50(2): 239-244.
[3] 韩雪,蒋国军,石巧娟. 降血糖药对内皮祖细胞作用的研究进展[J]. 浙江大学学报(医学版), 2020, 49(5): 629-636.
[4] 杨林东,包芳,吴元赭,孙丽洲. 晚期妊娠孕妇B群链球菌定植状况及妊娠结局分析[J]. 浙江大学学报(医学版), 2020, 49(3): 389-396.
[5] 陈旭,李央,王金希,蔡洪流,曹红翠,盛吉芳. 三例妊娠合并2019冠状病毒病(COVID-19)患者诊治分析[J]. 浙江大学学报(医学版), 2020, 49(2): 240-244.
[6] 林啸笑,孙待飞,傅君,钟惠珍. 子宫动脉栓塞术治疗产后出血对再次妊娠结局的影响[J]. 浙江大学学报(医学版), 2019, 48(5): 540-545.
[7] 梅瑾,刘姣,王敏,张闻,王昊,卢莎,何茶英,靳春雷. 八例22q11.2区微重复胎儿产前诊断和妊娠结局分析[J]. 浙江大学学报(医学版), 2019, 48(4): 429-433.
[8] 孙婷,徐明娟. 妊娠期正常高值血压产妇体质量及妊娠结局的回顾性分析[J]. 浙江大学学报(医学版), 2019, 48(2): 174-179.
[9] 李瑶,陈慧. 胰岛素瘤合并继发性肾上腺皮质功能不全一例[J]. 浙江大学学报(医学版), 2017, 46(6): 662-665.
[10] 李恩书 等. 不同氧浓度培养对体外受精-胚胎移植及子代出生缺陷的影响[J]. 浙江大学学报(医学版), 2017, 46(3): 290-294.
[11] 石碧炜 等. 胚胎冻融对卵裂期行植入前遗传学诊断或筛查后可移植胚胎临床结局的影响[J]. 浙江大学学报(医学版), 2017, 46(3): 295-299.
[12] 王结胜 等. 小檗碱抑制肠道二肽基肽酶-Ⅳ的降糖机制研究[J]. 浙江大学学报(医学版), 2016, 45(5): 486-492.
[13] 张坚贞, 贺晶. 再发子痫前期相关因素及母子转归的单中心临床研究[J]. 浙江大学学报(医学版), 2015, 44(3): 258-263.
[14] 沈亲亲, 张檀. 产前筛查血清学指标与不良妊娠结局关系的研究进展[J]. 浙江大学学报(医学版), 2015, 44(3): 339-343.
[15] 郭凤霞,曾阳,李锦萍. 苍耳水提物抑制α-葡萄糖苷酶活性及降低小鼠血糖的作用[J]. 浙江大学学报(医学版), 2013, 42(6): 632-637+665.